Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dutasteride Treatment for Reducing Heavy Drinking in AUD: Predictors of Efficacy

NCT04098302 is registered in ClinicalTrials.gov with UConn Health as lead sponsor.

NCT NCT04098302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04098302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dutasteride Treatment for Reducing Heavy Drinking in AUD: Predictors of Efficacy
Lead sponsor
UConn Health
Phase
Phase 2/3
Overall status
Completed
Start date
October 15, 2019
Completion date
June 28, 2024
Enrollment
180 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder